In most reports, macrophages present in the tumoral microenvironment are considered and classified as “tumor-associated macrophages.” Although KCs were initially thought to be only involved in antitumor immunity, there is substantial evidence that suggests that KCs are part of the TAM population and enhance tumor progression [3, 31–33]. The gene discussed is TBCE; the disease is neoplasm.